nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—CYP1B1—Dexamethasone—psoriatic arthritis	0.138	0.182	CbGbCtD
Mitoxantrone—ABCC1—Methotrexate—psoriatic arthritis	0.0788	0.104	CbGbCtD
Mitoxantrone—ABCG2—Dexamethasone—psoriatic arthritis	0.0656	0.0867	CbGbCtD
Mitoxantrone—ABCB1—Methylprednisolone—psoriatic arthritis	0.0626	0.0826	CbGbCtD
Mitoxantrone—ABCG2—Methotrexate—psoriatic arthritis	0.0527	0.0697	CbGbCtD
Mitoxantrone—CYP2E1—Dexamethasone—psoriatic arthritis	0.0468	0.0618	CbGbCtD
Mitoxantrone—ABCB1—Betamethasone—psoriatic arthritis	0.0407	0.0537	CbGbCtD
Mitoxantrone—ABCB1—Prednisolone—psoriatic arthritis	0.0401	0.053	CbGbCtD
Mitoxantrone—ABCB1—Prednisone—psoriatic arthritis	0.0379	0.0501	CbGbCtD
Mitoxantrone—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0375	0.0495	CbGbCtD
Mitoxantrone—CYP3A4—Triamcinolone—psoriatic arthritis	0.0284	0.0375	CbGbCtD
Mitoxantrone—CYP3A4—Betamethasone—psoriatic arthritis	0.0244	0.0322	CbGbCtD
Mitoxantrone—CYP3A4—Prednisolone—psoriatic arthritis	0.024	0.0318	CbGbCtD
Mitoxantrone—ABCB1—Dexamethasone—psoriatic arthritis	0.0237	0.0313	CbGbCtD
Mitoxantrone—CYP3A4—Prednisone—psoriatic arthritis	0.0227	0.03	CbGbCtD
Mitoxantrone—ABCB1—Methotrexate—psoriatic arthritis	0.019	0.0251	CbGbCtD
Mitoxantrone—CYP3A4—Dexamethasone—psoriatic arthritis	0.0142	0.0187	CbGbCtD
Mitoxantrone—TOP2A—Methyltestosterone—Prednisone—psoriatic arthritis	0.000795	0.506	CbGdCrCtD
Mitoxantrone—TOP2A—Methyltestosterone—Prednisolone—psoriatic arthritis	0.000776	0.494	CbGdCrCtD
Mitoxantrone—Bradycardia—Prednisone—psoriatic arthritis	0.00037	0.00153	CcSEcCtD
Mitoxantrone—Alopecia—Dexamethasone—psoriatic arthritis	0.000369	0.00153	CcSEcCtD
Mitoxantrone—Alopecia—Betamethasone—psoriatic arthritis	0.000369	0.00153	CcSEcCtD
Mitoxantrone—Discomfort—Prednisolone—psoriatic arthritis	0.000366	0.00152	CcSEcCtD
Mitoxantrone—Haemoglobin—Prednisone—psoriatic arthritis	0.000365	0.00151	CcSEcCtD
Mitoxantrone—Haemorrhage—Prednisone—psoriatic arthritis	0.000363	0.00151	CcSEcCtD
Mitoxantrone—Erythema—Dexamethasone—psoriatic arthritis	0.000363	0.00151	CcSEcCtD
Mitoxantrone—Erythema—Betamethasone—psoriatic arthritis	0.000363	0.00151	CcSEcCtD
Mitoxantrone—Malaise—Triamcinolone—psoriatic arthritis	0.000361	0.0015	CcSEcCtD
Mitoxantrone—Pancytopenia—Methotrexate—psoriatic arthritis	0.00036	0.00149	CcSEcCtD
Mitoxantrone—Malaise—Methylprednisolone—psoriatic arthritis	0.00036	0.00149	CcSEcCtD
Mitoxantrone—Oedema—Prednisolone—psoriatic arthritis	0.000355	0.00147	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000355	0.00147	CcSEcCtD
Mitoxantrone—Neutropenia—Methotrexate—psoriatic arthritis	0.000355	0.00147	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000353	0.00146	CcSEcCtD
Mitoxantrone—Shock—Prednisolone—psoriatic arthritis	0.00035	0.00145	CcSEcCtD
Mitoxantrone—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.000349	0.00145	CcSEcCtD
Mitoxantrone—Cough—Triamcinolone—psoriatic arthritis	0.000349	0.00145	CcSEcCtD
Mitoxantrone—Convulsion—Triamcinolone—psoriatic arthritis	0.000347	0.00144	CcSEcCtD
Mitoxantrone—Tachycardia—Prednisolone—psoriatic arthritis	0.000347	0.00144	CcSEcCtD
Mitoxantrone—Convulsion—Methylprednisolone—psoriatic arthritis	0.000346	0.00143	CcSEcCtD
Mitoxantrone—Hypertension—Triamcinolone—psoriatic arthritis	0.000346	0.00143	CcSEcCtD
Mitoxantrone—Hypertension—Methylprednisolone—psoriatic arthritis	0.000345	0.00143	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000343	0.00142	CcSEcCtD
Mitoxantrone—Myalgia—Triamcinolone—psoriatic arthritis	0.000341	0.00141	CcSEcCtD
Mitoxantrone—Pneumonia—Methotrexate—psoriatic arthritis	0.00034	0.00141	CcSEcCtD
Mitoxantrone—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00034	0.00141	CcSEcCtD
Mitoxantrone—Myalgia—Methylprednisolone—psoriatic arthritis	0.00034	0.00141	CcSEcCtD
Mitoxantrone—Anxiety—Methylprednisolone—psoriatic arthritis	0.000339	0.0014	CcSEcCtD
Mitoxantrone—Drowsiness—Methotrexate—psoriatic arthritis	0.000338	0.0014	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000337	0.0014	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000337	0.0014	CcSEcCtD
Mitoxantrone—Discomfort—Triamcinolone—psoriatic arthritis	0.000337	0.0014	CcSEcCtD
Mitoxantrone—Discomfort—Methylprednisolone—psoriatic arthritis	0.000336	0.00139	CcSEcCtD
Mitoxantrone—Renal failure—Methotrexate—psoriatic arthritis	0.000333	0.00138	CcSEcCtD
Mitoxantrone—Stomatitis—Methotrexate—psoriatic arthritis	0.00033	0.00137	CcSEcCtD
Mitoxantrone—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000329	0.00136	CcSEcCtD
Mitoxantrone—Confusional state—Methylprednisolone—psoriatic arthritis	0.000329	0.00136	CcSEcCtD
Mitoxantrone—Malaise—Betamethasone—psoriatic arthritis	0.000328	0.00136	CcSEcCtD
Mitoxantrone—Malaise—Dexamethasone—psoriatic arthritis	0.000328	0.00136	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000327	0.00135	CcSEcCtD
Mitoxantrone—Oedema—Triamcinolone—psoriatic arthritis	0.000327	0.00135	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000326	0.00135	CcSEcCtD
Mitoxantrone—Arrhythmia—Prednisone—psoriatic arthritis	0.000325	0.00135	CcSEcCtD
Mitoxantrone—Infection—Triamcinolone—psoriatic arthritis	0.000325	0.00135	CcSEcCtD
Mitoxantrone—Sweating—Methotrexate—psoriatic arthritis	0.000324	0.00134	CcSEcCtD
Mitoxantrone—Infection—Methylprednisolone—psoriatic arthritis	0.000324	0.00134	CcSEcCtD
Mitoxantrone—Haematuria—Methotrexate—psoriatic arthritis	0.000323	0.00134	CcSEcCtD
Mitoxantrone—Shock—Triamcinolone—psoriatic arthritis	0.000321	0.00133	CcSEcCtD
Mitoxantrone—Alopecia—Prednisone—psoriatic arthritis	0.000321	0.00133	CcSEcCtD
Mitoxantrone—Shock—Methylprednisolone—psoriatic arthritis	0.000321	0.00133	CcSEcCtD
Mitoxantrone—Paraesthesia—Prednisolone—psoriatic arthritis	0.000319	0.00132	CcSEcCtD
Mitoxantrone—Tachycardia—Triamcinolone—psoriatic arthritis	0.000319	0.00132	CcSEcCtD
Mitoxantrone—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000318	0.00132	CcSEcCtD
Mitoxantrone—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000317	0.00131	CcSEcCtD
Mitoxantrone—Erythema—Prednisone—psoriatic arthritis	0.000316	0.00131	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000316	0.00131	CcSEcCtD
Mitoxantrone—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000316	0.00131	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000315	0.00131	CcSEcCtD
Mitoxantrone—Convulsion—Dexamethasone—psoriatic arthritis	0.000315	0.0013	CcSEcCtD
Mitoxantrone—Convulsion—Betamethasone—psoriatic arthritis	0.000315	0.0013	CcSEcCtD
Mitoxantrone—Hypertension—Dexamethasone—psoriatic arthritis	0.000314	0.0013	CcSEcCtD
Mitoxantrone—Hypertension—Betamethasone—psoriatic arthritis	0.000314	0.0013	CcSEcCtD
Mitoxantrone—Myalgia—Betamethasone—psoriatic arthritis	0.000309	0.00128	CcSEcCtD
Mitoxantrone—Myalgia—Dexamethasone—psoriatic arthritis	0.000309	0.00128	CcSEcCtD
Mitoxantrone—Anxiety—Dexamethasone—psoriatic arthritis	0.000308	0.00128	CcSEcCtD
Mitoxantrone—Anxiety—Betamethasone—psoriatic arthritis	0.000308	0.00128	CcSEcCtD
Mitoxantrone—Discomfort—Dexamethasone—psoriatic arthritis	0.000306	0.00127	CcSEcCtD
Mitoxantrone—Discomfort—Betamethasone—psoriatic arthritis	0.000306	0.00127	CcSEcCtD
Mitoxantrone—Haemoglobin—Methotrexate—psoriatic arthritis	0.000305	0.00127	CcSEcCtD
Mitoxantrone—Hypotension—Methylprednisolone—psoriatic arthritis	0.000305	0.00126	CcSEcCtD
Mitoxantrone—Pain—Prednisolone—psoriatic arthritis	0.000304	0.00126	CcSEcCtD
Mitoxantrone—Haemorrhage—Methotrexate—psoriatic arthritis	0.000304	0.00126	CcSEcCtD
Mitoxantrone—Hepatitis—Methotrexate—psoriatic arthritis	0.000304	0.00126	CcSEcCtD
Mitoxantrone—Pharyngitis—Methotrexate—psoriatic arthritis	0.000301	0.00125	CcSEcCtD
Mitoxantrone—Vision blurred—Prednisone—psoriatic arthritis	0.000298	0.00124	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000298	0.00123	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000297	0.00123	CcSEcCtD
Mitoxantrone—Oedema—Betamethasone—psoriatic arthritis	0.000296	0.00123	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000296	0.00123	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000296	0.00123	CcSEcCtD
Mitoxantrone—Oedema—Dexamethasone—psoriatic arthritis	0.000296	0.00123	CcSEcCtD
Mitoxantrone—Infection—Betamethasone—psoriatic arthritis	0.000295	0.00122	CcSEcCtD
Mitoxantrone—Infection—Dexamethasone—psoriatic arthritis	0.000295	0.00122	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000294	0.00122	CcSEcCtD
Mitoxantrone—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000293	0.00122	CcSEcCtD
Mitoxantrone—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000293	0.00121	CcSEcCtD
Mitoxantrone—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000293	0.00121	CcSEcCtD
Mitoxantrone—Anaemia—Prednisone—psoriatic arthritis	0.000292	0.00121	CcSEcCtD
Mitoxantrone—Shock—Betamethasone—psoriatic arthritis	0.000292	0.00121	CcSEcCtD
Mitoxantrone—Shock—Dexamethasone—psoriatic arthritis	0.000292	0.00121	CcSEcCtD
Mitoxantrone—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000291	0.00121	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00029	0.0012	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00029	0.0012	CcSEcCtD
Mitoxantrone—Tachycardia—Dexamethasone—psoriatic arthritis	0.000289	0.0012	CcSEcCtD
Mitoxantrone—Tachycardia—Betamethasone—psoriatic arthritis	0.000289	0.0012	CcSEcCtD
Mitoxantrone—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000288	0.00119	CcSEcCtD
Mitoxantrone—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000287	0.00119	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000287	0.00119	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000287	0.00119	CcSEcCtD
Mitoxantrone—Malaise—Prednisone—psoriatic arthritis	0.000285	0.00118	CcSEcCtD
Mitoxantrone—Anorexia—Betamethasone—psoriatic arthritis	0.000283	0.00117	CcSEcCtD
Mitoxantrone—Anorexia—Dexamethasone—psoriatic arthritis	0.000283	0.00117	CcSEcCtD
Mitoxantrone—Urticaria—Prednisolone—psoriatic arthritis	0.000282	0.00117	CcSEcCtD
Mitoxantrone—Fatigue—Triamcinolone—psoriatic arthritis	0.000282	0.00117	CcSEcCtD
Mitoxantrone—Fatigue—Methylprednisolone—psoriatic arthritis	0.000281	0.00116	CcSEcCtD
Mitoxantrone—Pain—Triamcinolone—psoriatic arthritis	0.000279	0.00116	CcSEcCtD
Mitoxantrone—Hypotension—Dexamethasone—psoriatic arthritis	0.000277	0.00115	CcSEcCtD
Mitoxantrone—Hypotension—Betamethasone—psoriatic arthritis	0.000277	0.00115	CcSEcCtD
Mitoxantrone—Convulsion—Prednisone—psoriatic arthritis	0.000274	0.00114	CcSEcCtD
Mitoxantrone—Hypertension—Prednisone—psoriatic arthritis	0.000273	0.00113	CcSEcCtD
Mitoxantrone—Chills—Methotrexate—psoriatic arthritis	0.000273	0.00113	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00027	0.00112	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00027	0.00112	CcSEcCtD
Mitoxantrone—Myalgia—Prednisone—psoriatic arthritis	0.000269	0.00112	CcSEcCtD
Mitoxantrone—Arthralgia—Prednisone—psoriatic arthritis	0.000269	0.00112	CcSEcCtD
Mitoxantrone—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000269	0.00112	CcSEcCtD
Mitoxantrone—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000269	0.00111	CcSEcCtD
Mitoxantrone—Anxiety—Prednisone—psoriatic arthritis	0.000268	0.00111	CcSEcCtD
Mitoxantrone—Alopecia—Methotrexate—psoriatic arthritis	0.000268	0.00111	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000267	0.0011	CcSEcCtD
Mitoxantrone—Paraesthesia—Betamethasone—psoriatic arthritis	0.000266	0.0011	CcSEcCtD
Mitoxantrone—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000266	0.0011	CcSEcCtD
Mitoxantrone—Discomfort—Prednisone—psoriatic arthritis	0.000266	0.0011	CcSEcCtD
Mitoxantrone—Erythema—Methotrexate—psoriatic arthritis	0.000264	0.0011	CcSEcCtD
Mitoxantrone—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000262	0.00108	CcSEcCtD
Mitoxantrone—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000261	0.00108	CcSEcCtD
Mitoxantrone—Dyspepsia—Betamethasone—psoriatic arthritis	0.000261	0.00108	CcSEcCtD
Mitoxantrone—Urticaria—Triamcinolone—psoriatic arthritis	0.00026	0.00108	CcSEcCtD
Mitoxantrone—Urticaria—Methylprednisolone—psoriatic arthritis	0.000259	0.00107	CcSEcCtD
Mitoxantrone—Dysgeusia—Methotrexate—psoriatic arthritis	0.000259	0.00107	CcSEcCtD
Mitoxantrone—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000258	0.00107	CcSEcCtD
Mitoxantrone—Oedema—Prednisone—psoriatic arthritis	0.000258	0.00107	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000258	0.00107	CcSEcCtD
Mitoxantrone—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000258	0.00107	CcSEcCtD
Mitoxantrone—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000258	0.00107	CcSEcCtD
Mitoxantrone—Decreased appetite—Betamethasone—psoriatic arthritis	0.000258	0.00107	CcSEcCtD
Mitoxantrone—Infection—Prednisone—psoriatic arthritis	0.000257	0.00106	CcSEcCtD
Mitoxantrone—Back pain—Methotrexate—psoriatic arthritis	0.000256	0.00106	CcSEcCtD
Mitoxantrone—Fatigue—Dexamethasone—psoriatic arthritis	0.000256	0.00106	CcSEcCtD
Mitoxantrone—Fatigue—Betamethasone—psoriatic arthritis	0.000256	0.00106	CcSEcCtD
Mitoxantrone—Shock—Prednisone—psoriatic arthritis	0.000254	0.00105	CcSEcCtD
Mitoxantrone—Pain—Dexamethasone—psoriatic arthritis	0.000254	0.00105	CcSEcCtD
Mitoxantrone—Pain—Betamethasone—psoriatic arthritis	0.000254	0.00105	CcSEcCtD
Mitoxantrone—Tachycardia—Prednisone—psoriatic arthritis	0.000252	0.00104	CcSEcCtD
Mitoxantrone—Skin disorder—Prednisone—psoriatic arthritis	0.000251	0.00104	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00025	0.00103	CcSEcCtD
Mitoxantrone—Vision blurred—Methotrexate—psoriatic arthritis	0.000249	0.00103	CcSEcCtD
Mitoxantrone—Anorexia—Prednisone—psoriatic arthritis	0.000246	0.00102	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000245	0.00102	CcSEcCtD
Mitoxantrone—Anaemia—Methotrexate—psoriatic arthritis	0.000244	0.00101	CcSEcCtD
Mitoxantrone—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000244	0.00101	CcSEcCtD
Mitoxantrone—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000244	0.00101	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000242	0.001	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000242	0.001	CcSEcCtD
Mitoxantrone—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000241	0.000998	CcSEcCtD
Mitoxantrone—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00024	0.000995	CcSEcCtD
Mitoxantrone—Malaise—Methotrexate—psoriatic arthritis	0.000238	0.000988	CcSEcCtD
Mitoxantrone—Leukopenia—Methotrexate—psoriatic arthritis	0.000237	0.000981	CcSEcCtD
Mitoxantrone—Urticaria—Betamethasone—psoriatic arthritis	0.000236	0.000976	CcSEcCtD
Mitoxantrone—Urticaria—Dexamethasone—psoriatic arthritis	0.000236	0.000976	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000235	0.000975	CcSEcCtD
Mitoxantrone—Asthenia—Triamcinolone—psoriatic arthritis	0.000234	0.000972	CcSEcCtD
Mitoxantrone—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000234	0.000971	CcSEcCtD
Mitoxantrone—Body temperature increased—Betamethasone—psoriatic arthritis	0.000234	0.000971	CcSEcCtD
Mitoxantrone—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000234	0.000971	CcSEcCtD
Mitoxantrone—Abdominal pain—Betamethasone—psoriatic arthritis	0.000234	0.000971	CcSEcCtD
Mitoxantrone—Asthenia—Methylprednisolone—psoriatic arthritis	0.000234	0.000969	CcSEcCtD
Mitoxantrone—Paraesthesia—Prednisone—psoriatic arthritis	0.000232	0.000961	CcSEcCtD
Mitoxantrone—Cough—Methotrexate—psoriatic arthritis	0.000231	0.000956	CcSEcCtD
Mitoxantrone—Convulsion—Methotrexate—psoriatic arthritis	0.000229	0.000949	CcSEcCtD
Mitoxantrone—Dyspepsia—Prednisone—psoriatic arthritis	0.000227	0.000942	CcSEcCtD
Mitoxantrone—Chest pain—Methotrexate—psoriatic arthritis	0.000225	0.000933	CcSEcCtD
Mitoxantrone—Myalgia—Methotrexate—psoriatic arthritis	0.000225	0.000933	CcSEcCtD
Mitoxantrone—Arthralgia—Methotrexate—psoriatic arthritis	0.000225	0.000933	CcSEcCtD
Mitoxantrone—Decreased appetite—Prednisone—psoriatic arthritis	0.000224	0.00093	CcSEcCtD
Mitoxantrone—Rash—Prednisolone—psoriatic arthritis	0.000224	0.000928	CcSEcCtD
Mitoxantrone—Dermatitis—Prednisolone—psoriatic arthritis	0.000224	0.000928	CcSEcCtD
Mitoxantrone—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000223	0.000924	CcSEcCtD
Mitoxantrone—Fatigue—Prednisone—psoriatic arthritis	0.000223	0.000922	CcSEcCtD
Mitoxantrone—Headache—Prednisolone—psoriatic arthritis	0.000223	0.000922	CcSEcCtD
Mitoxantrone—Discomfort—Methotrexate—psoriatic arthritis	0.000222	0.000922	CcSEcCtD
Mitoxantrone—Constipation—Prednisone—psoriatic arthritis	0.000221	0.000915	CcSEcCtD
Mitoxantrone—Confusional state—Methotrexate—psoriatic arthritis	0.000218	0.000902	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000216	0.000894	CcSEcCtD
Mitoxantrone—Infection—Methotrexate—psoriatic arthritis	0.000214	0.000888	CcSEcCtD
Mitoxantrone—Feeling abnormal—Prednisone—psoriatic arthritis	0.000213	0.000882	CcSEcCtD
Mitoxantrone—Asthenia—Betamethasone—psoriatic arthritis	0.000213	0.000882	CcSEcCtD
Mitoxantrone—Asthenia—Dexamethasone—psoriatic arthritis	0.000213	0.000882	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000211	0.000876	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000211	0.000875	CcSEcCtD
Mitoxantrone—Nausea—Prednisolone—psoriatic arthritis	0.000211	0.000875	CcSEcCtD
Mitoxantrone—Skin disorder—Methotrexate—psoriatic arthritis	0.00021	0.000869	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000209	0.000864	CcSEcCtD
Mitoxantrone—Vomiting—Triamcinolone—psoriatic arthritis	0.000208	0.000861	CcSEcCtD
Mitoxantrone—Vomiting—Methylprednisolone—psoriatic arthritis	0.000207	0.000859	CcSEcCtD
Mitoxantrone—Rash—Triamcinolone—psoriatic arthritis	0.000206	0.000854	CcSEcCtD
Mitoxantrone—Dermatitis—Triamcinolone—psoriatic arthritis	0.000206	0.000853	CcSEcCtD
Mitoxantrone—Anorexia—Methotrexate—psoriatic arthritis	0.000206	0.000852	CcSEcCtD
Mitoxantrone—Rash—Methylprednisolone—psoriatic arthritis	0.000206	0.000852	CcSEcCtD
Mitoxantrone—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000205	0.000851	CcSEcCtD
Mitoxantrone—Urticaria—Prednisone—psoriatic arthritis	0.000205	0.00085	CcSEcCtD
Mitoxantrone—Headache—Triamcinolone—psoriatic arthritis	0.000205	0.000848	CcSEcCtD
Mitoxantrone—Headache—Methylprednisolone—psoriatic arthritis	0.000204	0.000846	CcSEcCtD
Mitoxantrone—Body temperature increased—Prednisone—psoriatic arthritis	0.000204	0.000846	CcSEcCtD
Mitoxantrone—Abdominal pain—Prednisone—psoriatic arthritis	0.000204	0.000846	CcSEcCtD
Mitoxantrone—Diarrhoea—Betamethasone—psoriatic arthritis	0.000203	0.000841	CcSEcCtD
Mitoxantrone—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000203	0.000841	CcSEcCtD
Mitoxantrone—Hypotension—Methotrexate—psoriatic arthritis	0.000202	0.000836	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000197	0.000815	CcSEcCtD
Mitoxantrone—Nausea—Triamcinolone—psoriatic arthritis	0.000194	0.000804	CcSEcCtD
Mitoxantrone—Paraesthesia—Methotrexate—psoriatic arthritis	0.000194	0.000803	CcSEcCtD
Mitoxantrone—Nausea—Methylprednisolone—psoriatic arthritis	0.000194	0.000803	CcSEcCtD
Mitoxantrone—Dyspnoea—Methotrexate—psoriatic arthritis	0.000192	0.000797	CcSEcCtD
Mitoxantrone—Somnolence—Methotrexate—psoriatic arthritis	0.000192	0.000795	CcSEcCtD
Mitoxantrone—Hypersensitivity—Prednisone—psoriatic arthritis	0.00019	0.000788	CcSEcCtD
Mitoxantrone—Dyspepsia—Methotrexate—psoriatic arthritis	0.00019	0.000787	CcSEcCtD
Mitoxantrone—Vomiting—Betamethasone—psoriatic arthritis	0.000189	0.000781	CcSEcCtD
Mitoxantrone—Vomiting—Dexamethasone—psoriatic arthritis	0.000189	0.000781	CcSEcCtD
Mitoxantrone—Decreased appetite—Methotrexate—psoriatic arthritis	0.000188	0.000777	CcSEcCtD
Mitoxantrone—Rash—Betamethasone—psoriatic arthritis	0.000187	0.000775	CcSEcCtD
Mitoxantrone—Rash—Dexamethasone—psoriatic arthritis	0.000187	0.000775	CcSEcCtD
Mitoxantrone—Dermatitis—Dexamethasone—psoriatic arthritis	0.000187	0.000774	CcSEcCtD
Mitoxantrone—Dermatitis—Betamethasone—psoriatic arthritis	0.000187	0.000774	CcSEcCtD
Mitoxantrone—Fatigue—Methotrexate—psoriatic arthritis	0.000186	0.000771	CcSEcCtD
Mitoxantrone—Headache—Dexamethasone—psoriatic arthritis	0.000186	0.00077	CcSEcCtD
Mitoxantrone—Headache—Betamethasone—psoriatic arthritis	0.000186	0.00077	CcSEcCtD
Mitoxantrone—Asthenia—Prednisone—psoriatic arthritis	0.000185	0.000768	CcSEcCtD
Mitoxantrone—Pain—Methotrexate—psoriatic arthritis	0.000185	0.000765	CcSEcCtD
Mitoxantrone—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000178	0.000737	CcSEcCtD
Mitoxantrone—Diarrhoea—Prednisone—psoriatic arthritis	0.000177	0.000732	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000176	0.000731	CcSEcCtD
Mitoxantrone—Nausea—Betamethasone—psoriatic arthritis	0.000176	0.00073	CcSEcCtD
Mitoxantrone—Nausea—Dexamethasone—psoriatic arthritis	0.000176	0.00073	CcSEcCtD
Mitoxantrone—Urticaria—Methotrexate—psoriatic arthritis	0.000171	0.00071	CcSEcCtD
Mitoxantrone—Body temperature increased—Methotrexate—psoriatic arthritis	0.000171	0.000707	CcSEcCtD
Mitoxantrone—Abdominal pain—Methotrexate—psoriatic arthritis	0.000171	0.000707	CcSEcCtD
Mitoxantrone—Vomiting—Prednisone—psoriatic arthritis	0.000164	0.00068	CcSEcCtD
Mitoxantrone—Rash—Prednisone—psoriatic arthritis	0.000163	0.000675	CcSEcCtD
Mitoxantrone—Dermatitis—Prednisone—psoriatic arthritis	0.000163	0.000674	CcSEcCtD
Mitoxantrone—Headache—Prednisone—psoriatic arthritis	0.000162	0.00067	CcSEcCtD
Mitoxantrone—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000159	0.000659	CcSEcCtD
Mitoxantrone—Asthenia—Methotrexate—psoriatic arthritis	0.000155	0.000642	CcSEcCtD
Mitoxantrone—Nausea—Prednisone—psoriatic arthritis	0.000153	0.000636	CcSEcCtD
Mitoxantrone—Diarrhoea—Methotrexate—psoriatic arthritis	0.000148	0.000612	CcSEcCtD
Mitoxantrone—Vomiting—Methotrexate—psoriatic arthritis	0.000137	0.000569	CcSEcCtD
Mitoxantrone—Rash—Methotrexate—psoriatic arthritis	0.000136	0.000564	CcSEcCtD
Mitoxantrone—Dermatitis—Methotrexate—psoriatic arthritis	0.000136	0.000563	CcSEcCtD
Mitoxantrone—Headache—Methotrexate—psoriatic arthritis	0.000135	0.00056	CcSEcCtD
Mitoxantrone—Nausea—Methotrexate—psoriatic arthritis	0.000128	0.000531	CcSEcCtD
